logo
#

Latest news with #Scott+Scott

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Western Asset Management Company, LLC
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Western Asset Management Company, LLC

Business Wire

time03-07-2025

  • Business
  • Business Wire

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Western Asset Management Company, LLC

NEW YORK--(BUSINESS WIRE)-- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Western District of Pennsylvania against Western Asset Management Company, LLC ('WAMCO' or the 'Company'), Franklin Resources, Inc. ('Franklin'), and Stephen Kenneth Leech, II ('Leech') (collectively, 'Defendants'). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b‑5) on behalf of all persons and entities that purchased and/or otherwise acquired shares of the 'Western Asset US Core Bond Fund' mutual fund classes – Class I (ticker: 'WATFX'), Class A (ticker: 'WABAX'), Class C (ticker: 'WABCX'), Class FI (ticker: 'WAPIX'), Class IS (ticker: 'WACSX'), and Class R (ticker: 'WABRX') – and the 'Western Asset Core Plus Bond Fund' mutual fund classes – Class A (ticker: 'WAPAX'), Class C (ticker: 'WAPCX'), Class C1 (ticker: 'LWCPX'), Class FI (ticker: 'WACIX'), Class R (ticker: 'WAPRX'), Class I (ticker: 'WACPX'), Class IS (ticker: 'WAPSX') – between January 1, 2021 and October 31, 2023, inclusive (the 'Class Period'), and were damaged thereby (the 'Class'). The Class Action filed by Scott+Scott is captioned: The Western PA Electrical Employees Insurance Trust Fund v. Western Asset Management Company, LLC, et al., Case No. 2:25-cv-00937. LEAD PLAINTIFF DEADLINE ON SEPTEMBER 2, 2025 WAMCO is a limited liability company, SEC-registered investment advisor, and specialist investment manager that is contracted by registered mutual funds and private funds to manage their investment portfolios and by other investment advisors as a sub-advisor. The Class Action alleges that, during the Class Period, Defendants made misleading statements and omissions regarding the Company's business, financial condition, and prospects. Specifically, Defendants failed to warn investors that: (1) Defendants favored certain WAMCO strategies, like Macro Opps, over other WAMCO strategies, like Core and Core Plus; (2) Defendants disfavored certain WAMCO strategies, like Core and Core Plus; (3) any 'compliance policies and procedures' that WAMCO maintained 'to result in fair allocations of investment opportunities to clients' were either insufficient to ensure that Leech and his WAMCO Team fairly allocated trades among the strategies they managed or were expressly disregarded by Defendants in order to allow the favoring of certain WAMCO strategies at the expense of other WAMCO strategies; and (4) any 'oversight mechanisms' that WAMCO maintained were either insufficient to monitor Leech and his WAMCO Team or were expressly disregarded by Defendants in order to allow the favoring of certain WAMCO strategies at the expense of other WAMCO strategies. As a result, Defendants' actions operated as a fraud or deceit on the Class, artificially reducing the price of the 'Western Asset US Core strategy' mutual fund classes during the Class Period, damaging Class members. LEAD PLAINTIFF DEADLINE ON SEPTEMBER 2, 2025 If you purchased and/or otherwise acquired shares of the 'Western Asset US Core Bond Fund' mutual fund classes identified above during the Class Period and were damaged thereby, you are a member of the 'Class' and may be able to seek appointment as lead plaintiff. If you wish to apply to be lead plaintiff, a motion on your behalf must be filed with the U.S. District Court for the Western District of Pennsylvania no later than September 2, 2025. The lead plaintiff is a court-appointed representative for absent class members of the Class. You do not need to seek appointment as lead plaintiff to share in any Class recovery in the Class Action. If you are a Class member and there is a recovery for the Class, you can share in that recovery as an absent Class member. If you wish to apply to be lead plaintiff, please contact attorney Nicholas Bruno at (888) 398-9312 or at nbruno@ What Can You Do? You may contact an attorney to discuss your rights regarding the appointment of lead plaintiff or your interest in the Class Action. You may retain counsel of your choice to represent you in the Class Action. About Scott+Scott Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoing, including securities law and shareholder violations. With more than 100 attorneys in eight offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit This may be considered Attorney Advertising.

Mastercard, Visa's merchant fees breach competition law, UK tribunal rules
Mastercard, Visa's merchant fees breach competition law, UK tribunal rules

Reuters

time27-06-2025

  • Business
  • Reuters

Mastercard, Visa's merchant fees breach competition law, UK tribunal rules

LONDON, June 27 (Reuters) - Global payments processors Visa (V.N), opens new tab and Mastercard's (MA.N), opens new tab default multilateral interchange fees which are charged to retailers infringe competition law, a London tribunal ruled on Friday in the latest round of the long-running legal saga. London's Competition Appeal Tribunal unanimously ruled that Visa and Mastercard's multilateral interchange fees breach European competition law, in a ruling in linked lawsuits brought by hundreds of merchants. David Scott, global managing partner of law firm Scott+Scott, which represented the claimants, said the ruling was "a significant win for all merchants who have been paying excessive interchange fees to Visa and Mastercard". Both Visa and Mastercard said they disagreed with the decision and intended to seek permission to appeal. A Visa spokesperson said: "Visa continues to believe that interchange is a critical component to maintaining a secure digital payments ecosystem that benefits all parties, including consumers, merchants and banks." "Mastercard strongly disagrees with today's decision, which is deeply flawed, and will seek permission to appeal," a Mastercard spokesperson said in a statement. Litigation over multilateral interchange fees, which are levied on retailers when cardholders make a transaction, has rumbled on for well over a decade in Britain and elsewhere. Scott+Scott said Friday's ruling was the first time that Visa and Mastercard's commercial card and inter-regional multilateral interchange fees had been found to infringe competition law. The liability trial which led to Friday's ruling took place in early 2024. A ruling following a further trial to determine whether any alleged overcharge was passed on by retailers to customers is pending.

AppLovin Investor Alert: Scott+Scott Attorneys at Law LLP Investigates AppLovin Corporation's Directors and Officers for Breach of Fiduciary Duties
AppLovin Investor Alert: Scott+Scott Attorneys at Law LLP Investigates AppLovin Corporation's Directors and Officers for Breach of Fiduciary Duties

Business Wire

time10-06-2025

  • Business
  • Business Wire

AppLovin Investor Alert: Scott+Scott Attorneys at Law LLP Investigates AppLovin Corporation's Directors and Officers for Breach of Fiduciary Duties

NEW YORK--(BUSINESS WIRE)-- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), an international securities and consumer rights litigation firm, is investigating whether the leadership of AppLovin Corporation ('AppLovin') (NASDAQ: APP) breached their fiduciary duties to AppLovin and its shareholders. Scott+Scott is investigating whether members of AppLovin's board of directors (the 'Board') made, or caused AppLovin to make, false and/or misleading statements, as well as failed to disclose material adverse facts, about AppLovin's business, operations, prospects, and financial health. Specifically, Scott+Scott is investigating whether the Board failed to disclose material information, including whether: (1) AppLovin is reverse-engineering and exploiting advertising data from Meta Platforms; (2) AppLovin is using manipulative practices to drive their own ad click-through and app download rates higher; (3) that, as a result, AppLovin was inflating installation numbers and thus its profit figures; and (4) as a result, statements about AppLovin's business, operations, and prospects lacked a reasonable basis. On February 26, 2025, two short reports were published, disclosing the above information. On this news, the stock price fell over 12.2%. What You Can Do – If you own shares of AppLovin, you may have legal claims against AppLovin's directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@ About Us Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoings, including securities law and shareholder violations. With more than 100 attorneys in nine offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit Attorney Advertising

Acadia Healthcare Investor Alert: Scott+Scott Attorneys at Law LLP Investigates Acadia Healthcare Company, Inc.'s Directors and Officers for Breach of Fiduciary Duties
Acadia Healthcare Investor Alert: Scott+Scott Attorneys at Law LLP Investigates Acadia Healthcare Company, Inc.'s Directors and Officers for Breach of Fiduciary Duties

Business Wire

time10-06-2025

  • Business
  • Business Wire

Acadia Healthcare Investor Alert: Scott+Scott Attorneys at Law LLP Investigates Acadia Healthcare Company, Inc.'s Directors and Officers for Breach of Fiduciary Duties

NEW YORK--(BUSINESS WIRE)-- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), an international securities and consumer rights litigation firm, is investigating whether the leadership of Acadia Healthcare Company, Inc. ('Acadia Healthcare') (NASDAQ: ACHC) breached their fiduciary duties to Acadia Healthcare and its shareholders. Scott+Scott is investigating whether members of the Acadia Healthcare board of directors or senior management failed to manage Acadia Healthcare in an acceptable manner, in breach of their fiduciary duties to Acadia Healthcare, and whether Acadia Healthcare and its shareholders have suffered damages as a result. New York Times published an investigative article detailing unlawful and unethical practices at Acadia Healthcare, including improperly detaining psychiatric patients in Acadia Healthcare facilities against their will. A second article was published on December 7, 2024, detailing fraud and falsification of records at Acadia Healthcare methadone clinics. On April 22, 2025, the New York Times published a third article regarding Acadia Healthcare, alleging suicides and rapes at one of Acadia Healthcare's facilities outside Chicago due in part to insufficient staffing. Acadia Healthcare has acknowledged several governmental investigations on the above, including by the Criminal Division of the U.S. Department of Justice and the Securities and Exchange Commission, as well as Congressional inquiries. In addition, a securities class action lawsuit has been filed against Acadia Healthcare and its top management. What You Can Do – CLICK HERE FOR YOUR OPTIONS AS A SHAREHOLDER If you own shares of Acadia Healthcare, you may have legal claims against Acadia Healthcare's directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@ About Us Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoings, including securities law and shareholder violations. With more than 100 attorneys in nine offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit Attorney Advertising

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Reckitt Benckiser Group PLC (OTC: RBGLY)
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Reckitt Benckiser Group PLC (OTC: RBGLY)

Business Wire

time05-06-2025

  • Business
  • Business Wire

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Reckitt Benckiser Group PLC (OTC: RBGLY)

NEW YORK--(BUSINESS WIRE)-- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Southern District of New York against Reckitt Benckiser Group PLC ('Reckitt' or the 'Company') (OTC: RBGLY), and certain of its former and current officers and/or directors (collectively, 'Defendants'). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b‑5) on behalf of all persons other than Defendants who purchased or otherwise acquired Reckitt American Depositary Shares ('ADSs') between January 13, 2021, and July 28, 2024, inclusive (the 'Class Period'), and were damaged thereby (the 'Class'). The Class Action filed by Scott+Scott is captioned: Elevator Constructors Union Local No. 1 Annuity & 401(K) Fund v. Reckitt Benckiser Group PLC, et al., Case No. 1:25-cv-4708. Reckitt is a United Kingdom-based, global consumer goods company. To date, over 500 state and federal products liability lawsuits have been filed against Reckitt and its competitor, Abbott Laboratories ('Abbott'), claiming that they failed to adequately warn that premature infants consuming cow milk-based formulas, such as Reckitt's Enfamil and Abbott's Similac, have an increased risk of developing necrotizing enterocolitis ('NEC'), a life-threatening intestinal disease that affects premature or low birth weight infants. The Class Action alleges that, during the Class Period, Defendants made misleading statements and omissions regarding the Company's business, financial condition, and prospects. Specifically, Defendants failed to warn investors and consumers: (1) that preterm infants were at an increased risk of developing NEC by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, Defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. The market began to learn the truth on March 15, 2024, when, in the case captioned Watson vs. Mead Johnson Co., Case No. 21-L-1032 (Ill. Cir. Ct. Oct. 28, 2021), a jury in St. Clair County, Illinois, returned a $60 million verdict in the first NEC lawsuit to be tried to a verdict. The jury found that Mead Johnson was negligent and failed to warn the decedent's mother of the increased risk her preterm infant could develop NEC by consuming cow's milk-based formula. On this news, the price of the Company's ADSs fell $1.87, or nearly 14%, from a closing price of $13.31 per share on March 14, 2024, to a closing price of $11.44 per share on March 15, 2024. Then, on July 29, 2024, the market continued to learn the truth when, in the case captioned Gill v. Abbot Laboratories, Inc., Case No. 2322-CC1251 (Mo. Circ. Ct. Jun. 23, 2023), a jury in St. Louis, Missouri, concluded that Abbott's specialized formula for premature babies led to a baby developing NEC and awarded the plaintiff $495 million. On this news, the price of the Company's ADSs fell $1.02, or nearly 9%, from a closing price of $11.66 per share on July 28, 2024, to a closing price of $10.64 per share on July 29, 2024. LEAD PLAINTIFF DEADLINE ON AUGUST 4, 2025 If you purchased Reckitt ADSs during the Class Period and were damaged thereby, you are a member of the 'Class' and may be able to seek appointment as lead plaintiff. If you wish to apply to be lead plaintiff, a motion on your behalf must be filed with the U.S. District Court for the Southern District of New York no later than August 4, 2025. The lead plaintiff is a court-appointed representative for absent class members of the Class. You do not need to seek appointment as lead plaintiff to share in any Class recovery in the Class Action. If you are a Class member and there is a recovery for the Class, you can share in that recovery as an absent Class member. If you wish to apply to be lead plaintiff, please contact attorney Nicholas Bruno at (888) 398-9312 or at nbruno@ What Can You Do? You may contact an attorney to discuss your rights regarding the appointment of lead plaintiff or your interest in the Class Action. You may retain counsel of your choice to represent you in the Class Action. About Scott+Scott Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoing, including securities law and shareholder violations. With more than 100 attorneys in eight offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit This may be considered Attorney Advertising.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store